Autor: "Al Mahmeed, W." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review.
Autorzy:: Pantea Stoian A; Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021, Bucharest, Romania.
Bica IC; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021, Bucharest, Romania. .
Salmen T; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021, Bucharest, Romania.
Al Mahmeed W; Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.
Al-Rasadi K; Medical Research Center, Sultan Qaboos University, Muscat, Oman.
Al-Alawi K; Department of Training and Studies, Royal Hospital, Ministry of Health, Muscat, Oman.
Banach M; Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.
Banerjee Y; Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.
Ceriello A; IRCCS MultiMedica, Milan, Italy.
Cesur M; Clinic of Endocrinology, Ankara Güven Hospital, Ankara, Turkey.
Cosentino F; Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, University of Stockholm, Stockholm, Sweden.
Firenze A; Unit of Research and International Cooperation, University Hospital of Palermo, Palermo, Italy.
Galia M; Department of Biomedicine, Neurosciences and Advanced Diagnostics (Bind), University of Palermo, Palermo, Italy.
Goh SY; Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
Janez A; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.
Kalra S; Department of Endocrinology, Bharti Hospital and Bride, Karnal, India.
Kapoor N; Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India.; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Kempler P; Department of Medicine and Oncology, Semmelweis University, Budapest, Hungary.
Lessan N; The Research Institute, Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.
Lotufo P; Center for Clinical and Epidemiological Research, University Hospital, University of São Paulo, Sao Paulo, Brazil.
Mikhailidis DP; Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.; Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, UK.
Nibali L; Dental Institute, Periodontology Unit, Centre for Host-Microbiome Interactions, King's College London, London, UK.
Papanas N; Diabetes Center, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
Powell-Wiley T; Social Determinants of Obesity and Cardiovascular Risk Laboratory, Cardiovascular Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Rizvi AA; Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, USA.
Sahebkar A; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sci-Ences, Mashhad, Iran.; Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Santos RD; Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Toth PP; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.; Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medi-Cine, Baltimore, MD, USA.
Viswanathan V; Diabetes Research Centre, Chennai, India.
Rizzo M; Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMise), School of Medicine, University of Palermo, Palermo, Italy.; Pokaż więcej
Corporate Authors:: Cardiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO)
Źródło:: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2024 Jan; Vol. 15 (1), pp. 33-60. Date of Electronic Publication: 2023 Sep 26.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review.
Autorzy:: Pantea Stoian A; Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021, Bucharest, Romania.
Bica IC; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021, Bucharest, Romania. .
Salmen T; Doctoral School, 'Carol Davila' University of Medicine and Pharmacy, 020021, Bucharest, Romania.
Al Mahmeed W; Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.
Al-Rasadi K; Medical Research Center, Sultan Qaboos University, Muscat, Oman.
Al-Alawi K; Department of Training and Studies, Royal Hospital, Ministry of Health, Muscat, Oman.
Banach M; Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.
Banerjee Y; Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.
Ceriello A; IRCCS MultiMedica, Milan, Italy.
Cesur M; Clinic of Endocrinology, Ankara Güven Hospital, Ankara, Turkey.
Cosentino F; Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, University of Stockholm, Stockholm, Sweden.
Firenze A; Unit of Research and International Cooperation, University Hospital of Palermo, Palermo, Italy.
Galia M; Department of Biomedicine, Neurosciences and Advanced Diagnostics (Bind), University of Palermo, Palermo, Italy.
Goh SY; Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
Janez A; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.
Kalra S; Department of Endocrinology, Bharti Hospital and Bride, Karnal, India.
Kapoor N; Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India.; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Kempler P; Department of Medicine and Oncology, Semmelweis University, Budapest, Hungary.
Lessan N; The Research Institute, Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.
Lotufo P; Center for Clinical and Epidemiological Research, University Hospital, University of São Paulo, Sao Paulo, Brazil.
Mikhailidis DP; Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.; Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, UK.
Nibali L; Dental Institute, Periodontology Unit, Centre for Host-Microbiome Interactions, King's College London, London, UK.
Papanas N; Diabetes Center, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
Powell-Wiley T; Social Determinants of Obesity and Cardiovascular Risk Laboratory, Cardiovascular Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Rizvi AA; Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, USA.
Sahebkar A; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sci-Ences, Mashhad, Iran.; Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Santos RD; Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Toth PP; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.; Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medi-Cine, Baltimore, MD, USA.
Viswanathan V; Diabetes Research Centre, Chennai, India.
Rizzo M; Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Department of Biochemistry, Mohamed Bin Rashid University, Dubai, United Arab Emirates.; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMise), School of Medicine, University of Palermo, Palermo, Italy.; Pokaż więcej
Corporate Authors:: Cardiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO)
Źródło:: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2024 Jan; Vol. 15 (1), pp. 297-299.
Typ publikacji:: Published Erratum

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact.
Autorzy:: Kapoor N; Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India.; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Kalra S; Department of Endocrinology, Bharti Hospital, B.R.I.D.E., Karnal, 132001, India. .
Al Mahmeed W; Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.
Al-Rasadi K; Medical Research Center, Sultan Qaboos University, Muscat, Oman.
Al-Alawi K; Department of Training and Studies, Royal Hospital, Ministry of Health, Muscat, Oman.
Banach M; Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.; Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.
Banerjee Y; Department of Biochemistry, Mohammed Bin Rashid University, Dubai, United Arab Emirates.
Ceriello A; IRCCS MultiMedica, Milan, Italy.
Cesur M; Clinic of Endocrinology, Ankara Güven Hospital, Ankara, Turkey.
Cosentino F; Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, University of Stockholm, Stockholm, Sweden.
Firenze A; Unit of Research and International Cooperation, University Hospital of Palermo, Palermo, Italy.
Galia M; Department of Biomedicine, Neurosciences and Advanced Diagnostics (Bind), University of Palermo, Palermo, Italy.
Goh SY; Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.
Janez A; Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.
Kempler P; Department of Medicine and Oncology, Semmelweis University, Budapest, Hungary.
Lessan N; The Research Institute, Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates.
Lotufo P; Center for Clinical and Epidemiological Research, University Hospital, University of São Paulo, São Paulo, Brazil.
Papanas N; Diabetes Center, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
Rizvi AA; Department of Medicine, University of Central Florida College of Medicine, Orlando, FL, USA.
Sahebkar A; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.; Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Santos RD; Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.; Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Stoian AP; Faculty of Medicine, Diabetes, Nutrition and Metabolic Diseases, Carol Davila University, Bucharest, Romania.
Toth PP; Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Viswanathan V; Diabetes Research Centre, Chennai, India.
Rizzo M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (Promise), School of Medicine, University of Palermo, Palermo, Italy.; Pokaż więcej
Corporate Authors:: CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO)
Źródło:: Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2022 Oct; Vol. 13 (10), pp. 1723-1736. Date of Electronic Publication: 2022 Aug 27.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Mortality and Morbidity in HF r EF, HF mr EF, and HF p EF Patients with Diabetes in the Middle East.
Autorzy:: Al-Jarallah M; Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al-Amiri Hospital, Kuwait City, Kuwait.
Rajan R; Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al-Amiri Hospital, Kuwait City, Kuwait.
Al-Zakwani I; Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman and Gulf Health Research, Muscat, Oman.
Dashti R; Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al-Amiri Hospital, Kuwait City, Kuwait.
Bulbanat B; Department of Cardiology, Sabah Al Ahmed Cardiac Centre, Al-Amiri Hospital, Kuwait City, Kuwait.
Ridha M; Division of Cardiology, Al-Dabous Cardiac Centre, Al Adan Hospital, Kuwait City, Kuwait.
Sulaiman K; Department of Cardiology, Royal Hospital, and Director General of Specialized Medical Care, Ministry of Health, Muscat, Oman.
Alsheikh-Ali AA; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
Panduranga P; Department of Cardiology, Royal Hospital, Muscat, Oman.
AlHabib KF; Department of Cardiac Sciences, King Fahad Cardiac Centre, King Saud University, Riyadh, Saudi Arabia.
Al Suwaidi J; Department of Adult Cardiology, Hamad Medical Corporation and Qatar Cardiovascular Research Centre, Doha, Qatar.
Al-Mahmeed W; Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi, UAE.
AlFaleh H; Department of Cardiac Sciences, King Fahad Cardiac Centre, King Saud University, Riyadh, Saudi Arabia.
Elasfar A; Department of Adult Cardiology, King Salman Heart Centre, King Fahad Medical City, Riyadh, Saudi Arabia, and Cardiology Department, Tanta University, Tanta, Egypt.
Al-Motarreb A; Department of Internal Medicine, Faculty of Medicine, Sana'a University, Sana'a, Yemen.
Bazargani N; Department of Cardiology, Dubai Hospital, Dubai, UAE.
Asaad N; Department of Adult Cardiology, Hamad Medical Corporation and Qatar Cardiovascular Research Centre, Doha, Qatar.
Amin H; Mohammed Bin Khalifa Cardiac Centre, Manama, Bahrain.; Pokaż więcej
Źródło:: Oman medical journal [Oman Med J] 2020 Feb 18; Vol. 35 (1), pp. e99. Date of Electronic Publication: 2020 Feb 18 (Print Publication: 2020).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Prevalence of Lipid Abnormalities and Cholesterol Target Value Attainment in Patients with Stable and Acute Coronary Heart Disease in the United Arab Emirates.
Autorzy:: Al Mahmeed W; Cleveland Clinic, Heart and Vascular Institute, Sheikh Khalifa Medical City, Abu Dhabi, Dubai, UAE.; Department of Cardiology, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Bakir S; Department of Cardiology, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Beshyah SA; Department of Cardiology, Sheikh Khalifa Medical City, Abu Dhabi, UAE.
Morcos B; Merck Sharp and Dohme, Dubai, UAE.
Wajih S; Merck Sharp and Dohme, Dubai, UAE.
Horack M; Foundation Institute for Myocardial Infarction Research, Ludwigshafen, Germany.
Lautsch D; Merck and Co., Inc., Kenilworth, NJ, USA.
Ambegaonkar B; Merck and Co., Inc., Kenilworth, NJ, USA.
Brudi P; Merck and Co., Inc., Kenilworth, NJ, USA.
Baxter CA; MSD Ltd., Hoddesdon, UK.
Vyas A; Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.
Gitt AK; Foundation Institute for Myocardial Infarction Research, Ludwigshafen, Germany.; Medical Department B, Hospital Ludwigshafen, Ludwigshafen, Germany.; Pokaż więcej
Źródło:: Heart views : the official journal of the Gulf Heart Association [Heart Views] 2019 Apr-Jun; Vol. 20 (2), pp. 37-46.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Patterns of tobacco use in the United Arab Emirates Healthy Future (UAEHFS) pilot study.
Autorzy:: Al-Houqani M; College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Leinberger-Jabari A; Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Al Naeemi A; Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Al Junaibi A; Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Al Zaabi E; Department of Pathology, Sheikh Khalifa Medical Center, Abu Dhabi, United Arab Emirates.
Oumeziane N; Department of Pathology, Sheikh Khalifa Medical Center, Abu Dhabi, United Arab Emirates.
Kazim M; Department of Pathology, Sheikh Khalifa Medical Center, Abu Dhabi, United Arab Emirates.
Al Maskari F; College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Al Dhaheri A; College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Abdel Wareth L; Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates.
Al Mahmeed W; Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Alsafar H; Department of Biomedical Engineering, Khalifa University, Abu Dhabi, United Arab Emirates.
Al Anouti F; College of Natural and Health Sciences, Zayed University, Abu Dhabi, United Arab Emirates.
Abdulle A; Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Inman CK; Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Al Hamiz A; Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Haji M; Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Ahn J; Department of Population Health, NYU School of Medicine, New York, New York, United States of America.; Permutter Cancer Center, New York University, New York, New York, United States of America.
Kirchhoff T; Department of Population Health, NYU School of Medicine, New York, New York, United States of America.
Hayes RB; Department of Population Health, NYU School of Medicine, New York, New York, United States of America.; Permutter Cancer Center, New York University, New York, New York, United States of America.
Ramasamy R; Department of Population Health, NYU School of Medicine, New York, New York, United States of America.
Schmidt AM; Department of Population Health, NYU School of Medicine, New York, New York, United States of America.
El Shahawy O; Department of Population Health, NYU School of Medicine, New York, New York, United States of America.
Weitzman M; Department of Population Health, NYU School of Medicine, New York, New York, United States of America.
Ali R; Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Sherman S; Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.; Department of Population Health, NYU School of Medicine, New York, New York, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2018 May 30; Vol. 13 (5), pp. e0198119. Date of Electronic Publication: 2018 May 30 (Print Publication: 2018).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Tobacco Use/*epidemiology
Adult ; Female ; Health Surveys ; Humans ; Male ; Pilot Projects ; Self Report ; United Arab Emirates/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study.
Autorzy:: Al-Zakwani I; Department of Pharmacology & Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, PO Box 38, PC-123, Al-Khodh, Sultanate of Oman. ial_.; Gulf Health Research, Muscat, Oman. ial_.
Al-Mahruqi F; College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman.
Al-Rasadi K; Department of Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman.
Shehab A; UAE University, Al-Ain, UAE.
Al Mahmeed W; Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi, UAE.
Arafah M; King Saud University Hospital, Riyadh, Saudi Arabia.
Al-Hinai AT; Ministry of Health, Muscat, Oman.
Al Tamimi O; Hamad Medical Corporation, Doha, Qatar.
Al Awadhi M; Al-Amiri Hospital, Kuwait City, Kuwait.
Santos RD; Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao, Paulo, Brazil.; Pokaż więcej
Źródło:: Lipids in health and disease [Lipids Health Dis] 2018 Feb 05; Vol. 17 (1), pp. 25. Date of Electronic Publication: 2018 Feb 05.
Typ publikacji:: Journal Article
MeSH Terms:: Atherosclerosis/*drug therapy
Diabetes Mellitus/*drug therapy
Dyslipidemias/*drug therapy
Hypolipidemic Agents/*therapeutic use
Adult ; Aged ; Atherosclerosis/epidemiology ; Atherosclerosis/pathology ; Atorvastatin/therapeutic use ; Cholesterol, LDL/blood ; Diabetes Mellitus/blood ; Diabetes Mellitus/epidemiology ; Diabetes Mellitus/pathology ; Dyslipidemias/blood ; Dyslipidemias/epidemiology ; Dyslipidemias/pathology ; Female ; Humans ; Male ; Middle Aged ; Middle East/epidemiology ; Rosuvastatin Calcium/therapeutic use ; Sex Characteristics ; Simvastatin/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
Autorzy:: Bassand JP; Department of Cardiology-EA 3920, University of Besançon, Besançon, France.; Thrombosis Research Institute, London, United Kingdom.
Accetta G; Thrombosis Research Institute, London, United Kingdom.
Al Mahmeed W; Cardiology, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Corbalan R; Department of Cardiology, Catholic University School of Medicine, Santiago, Chile.
Eikelboom J; Department of Medicine, McMaster University, Hamilton, Canada.
Fitzmaurice DA; Warwick Medical School, University of Warwick, Coventry, United Kingdom.
Fox KAA; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Gao H; Thrombosis Research Institute, London, United Kingdom.
Goldhaber SZ; Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
Goto S; Department of Medicine (Cardiology), Tokai University School of Medicine, Kanagawa, Japan.
Haas S; Formerly Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Kayani G; Thrombosis Research Institute, London, United Kingdom.
Pieper K; Thrombosis Research Institute, London, United Kingdom.; Duke Clinical Research Institute, Durham, North Carolina, United States of America.
Turpie AGG; Department of Medicine, McMaster University, Hamilton, Canada.
van Eickels M; Bayer AG, Berlin, Germany.
Verheugt FWA; Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
Kakkar AK; Thrombosis Research Institute, London, United Kingdom.; University College London, London, United Kingdom.; Pokaż więcej
Corporate Authors:: GARFIELD-AF Investigators
Źródło:: PloS one [PLoS One] 2018 Jan 25; Vol. 13 (1), pp. e0191592. Date of Electronic Publication: 2018 Jan 25 (Print Publication: 2018).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Fibrillation/*epidemiology
Atrial Fibrillation/*mortality
Aged ; Aged, 80 and over ; Anticoagulants/therapeutic use ; Atrial Fibrillation/complications ; Atrial Fibrillation/drug therapy ; Cohort Studies ; Comorbidity ; Death ; Female ; Fibrinolytic Agents/therapeutic use ; Heart Failure/complications ; Hemorrhage/chemically induced ; Hemorrhage/epidemiology ; Humans ; Male ; Prospective Studies ; Registries ; Renal Insufficiency, Chronic/complications ; Risk Assessment ; Risk Factors ; Stroke/epidemiology ; Treatment Outcome ; Vascular Diseases/complications

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: The UAE healthy future study: a pilot for a prospective cohort study of 20,000 United Arab Emirates nationals.
Autorzy:: Abdulle A; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Alnaeemi A; Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Aljunaibi A; Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Al Ali A; Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Al Saedi K; Zayed Military Hospital, Abu Dhabi, United Arab Emirates.
Al Zaabi E; Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Oumeziane N; Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Al Bastaki M; Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Al-Houqani M; UAE University, Al-Ain, United Arab Emirates.
Al Maskari F; UAE University, Al-Ain, United Arab Emirates.
Al Dhaheri A; UAE University, Al-Ain, United Arab Emirates.
Shah SM; UAE University, Al-Ain, United Arab Emirates.
Loney T; UAE University, Al-Ain, United Arab Emirates.
El-Sadig M; UAE University, Al-Ain, United Arab Emirates.
Oulhaj A; UAE University, Al-Ain, United Arab Emirates.
Wareth LA; Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Al Mahmeed W; Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Alsafar H; Khalifa University of Science Technology & Research, Abu Dhabi, United Arab Emirates.
Hirsch B; Khalifa University of Science Technology & Research, Abu Dhabi, United Arab Emirates.
Al Anouti F; Zayed University, Abu Dhabi, United Arab Emirates.
Yaaqoub J; Abu Dhabi Police Medical Services, Abu Dhabi, United Arab Emirates.
Inman CK; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Al Hamiz A; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Al Hosani A; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Haji M; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Alsharid T; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Al Zaabi T; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Al Maisary F; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Galani D; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
Sprosen T; University of Oxford, Oxford, UK.
El Shahawy O; New York University School of Medicine, New York, NY, USA.
Ahn J; New York University School of Medicine, New York, NY, USA.
Kirchhoff T; New York University School of Medicine, New York, NY, USA.
Ramasamy R; New York University School of Medicine, New York, NY, USA.
Schmidt AM; New York University School of Medicine, New York, NY, USA.
Hayes R; New York University School of Medicine, New York, NY, USA.
Sherman S; New York University School of Medicine, New York, NY, USA.
Ali R; New York University Abu Dhabi, Abu Dhabi, United Arab Emirates. .; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2018 Jan 05; Vol. 18 (1), pp. 101. Date of Electronic Publication: 2018 Jan 05.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Noncommunicable Diseases/*epidemiology
Adolescent ; Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies ; Risk Factors ; Surveys and Questionnaires ; United Arab Emirates/epidemiology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Impact of metabolic syndrome on lipid target achievements in the Arabian Gulf: findings from the CEPHEUS study.
Autorzy:: Al-Zakwani I; Department of Pharmacology & Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman ; Gulf Health Research, Muscat, Oman.
Al Mahmeed W; Heart and Vascular Institute-Cleveland Clinic, Abu Dhabi, United Arab Emirates.
Shehab A; UAE University, Alain, United Arab Emirates.
Arafah M; King Saud University Hospital, Riyadh, Kingdom of Saudi Arabia.
Al-Hinai AT; Ministry of Health, Muscat, Oman.
Al Tamimi O; Hamad Medical Corporation, Doha, Qatar.
Al Awadhi M; Al Amiri Hospital, Kuwait City, Kuwait.
Al Herz S; King Fahad National Guard Hospital, Riyadh, Kingdom of Saudi Arabia.
Al Anazi F; Ministry of Health, Riyadh, Kingdom of Saudi Arabia.
Al Nemer K; School of Medicine, Al-Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Kingdom of Saudi Arabia.
Metwally O; King Fahad General Hospital, Jeddah, Kingdom of Saudi Arabia.
Alkhadra A; King Fahad Hospital of the University, Khobar, Kingdom of Saudi Arabia.
Fakhry M; King Fahad Hospital of the University, Khobar, Kingdom of Saudi Arabia.
Elghetany H; Soliman Fakieh Hospital, Jeddah, Kingdom of Saudi Arabia.
Medani AR; Dubai Hospital, Dubai, United Arab Emirates.
Yusufali AH; Dubai Hospital, Dubai, United Arab Emirates.
Al Jassim O; Dubai Hospital, Dubai, United Arab Emirates.
Al Hallaq O; American Hospital, Dubai, United Arab Emirates.
Baslaib FO; Rashid Hospital, Dubai, United Arab Emirates.
Amin H; Bahrain Defense Force Hospital, Manama, Bahrain.
Al-Waili K; Department of Biochemistry, Sultan Qaboos University Hospital, P.O. Box 38, Al-Khod, 123 Muscat, Oman.
Al-Hashmi K; Department of Physiology, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman.
Santos RD; Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.
Al-Rasadi K; Department of Biochemistry, Sultan Qaboos University Hospital, P.O. Box 38, Al-Khod, 123 Muscat, Oman.; Pokaż więcej
Źródło:: Diabetology & metabolic syndrome [Diabetol Metab Syndr] 2016 Jul 26; Vol. 8, pp. 49. Date of Electronic Publication: 2016 Jul 26 (Print Publication: 2016).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE).
Autorzy:: Sulaiman K; Department of Cardiology, Royal Hospital, Muscat, Oman.
Panduranga P
Al-Zakwani I
Alsheikh-Ali AA
AlHabib KF
Al-Suwaidi J
Al-Mahmeed W
AlFaleh H
Elasfar A
Al-Motarreb A
Ridha M
Bulbanat B
Al-Jarallah M
Bazargani N
Asaad N
Amin H; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2015 Apr; Vol. 17 (4), pp. 374-84. Date of Electronic Publication: 2015 Mar 04.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Registries*
Heart Failure/*drug therapy
Heart Failure/*epidemiology
Adrenergic beta-Antagonists/therapeutic use ; Adult ; Age Factors ; Aged ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Atrial Fibrillation/epidemiology ; Coronary Artery Disease/epidemiology ; Diabetes Mellitus/epidemiology ; Female ; Heart Failure/physiopathology ; Humans ; Hypertension/epidemiology ; Male ; Middle Aged ; Middle East/epidemiology ; Prospective Studies ; Stroke Volume/physiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Rationale, Design, Methodology and Hospital Characteristics of the First Gulf Acute Heart Failure Registry (Gulf CARE).
Autorzy:: Sulaiman KJ; Department of Cardiology, Royal Hospital, Muscat, Oman.
Panduranga P; Department of Cardiology, Royal Hospital, Muscat, Oman.
Al-Zakwani I; Department of Pharmacology and Clinical Pharmacy, Sultan Qaboos University and Gulf Health Research, Muscat, Oman.
Alsheikh-Ali A; Department of Cardiology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Al-Habib K; Department of Cardiology, King Fahad Cardiac Centre, King Khalid University Hospital, College of Medicine, Riyadh, Saudi Arabia.
Al-Suwaidi J; Department of Cardiology, Hamad General Hospital, Doha, Qatar.
Al-Mahmeed W; Department of Cardiology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
Al-Faleh H; Department of Cardiology and Cardiovascular Surgery, Security Forces Hospital, Riyadh, Saudi Arabia.
El-Asfar A; Department of Cardiology, Prince Salman Cardiac Center, Saudi Arabia.
Al-Motarreb A; Department of Medicine, Sana'a University, Sana'a, Yemen.
Ridha M; Department of Cardiology, Adan Hospital, Kuwait.
Bulbanat B; Department of Cardiology, Al-Amiri Hospital, Saudi Arabia.
Al-Jarallah M; Department of Cardiology, Al-Amiri Hospital, Saudi Arabia.
Bazargani N; Department of Cardiology, Dubai Hospital, Dubai, United Arab Emirates.
Asaad N; Department of Cardiology, Hamad General Hospital, Doha, Qatar.
Amin H; Department of Cardiology, Mohammed Bin Khalifa Cardiac Centre, Bahrain.; Pokaż więcej
Źródło:: Heart views : the official journal of the Gulf Heart Association [Heart Views] 2014 Jan; Vol. 15 (1), pp. 6-12.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Impact of anemia on in-hospital, one-month and one-year mortality in patients with acute coronary syndrome from the Middle East.
Autorzy:: Sulaiman K; Department of Cardiology, Royal Hospital, PO Box 1331, Muscat PC-111, Sultanate of Oman. />Prashanth P
Al-Zakwani I
Al-Mahmeed W
Al-Motarreb A
Al Suwaidi J
Amin H
Asaad N
Hersi A
Al Faleh H
Al Saif S
Alsheikh-Ali AA
Al Lawati J
Al-Habib K; Pokaż więcej
Źródło:: Clinical medicine & research [Clin Med Res] 2012 May; Vol. 10 (2), pp. 65-71.
Typ publikacji:: Journal Article
MeSH Terms:: Acute Coronary Syndrome/*complications
Acute Coronary Syndrome/*mortality
Anemia/*complications
Anemia/*mortality
Aged ; Cohort Studies ; Female ; Follow-Up Studies ; Heart Failure/complications ; Hemoglobins/analysis ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Middle East/epidemiology ; Myocardial Infarction/complications ; Recurrence ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Shock, Cardiogenic/complications ; Stroke/complications

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: The prevalence and outcome of hypertension in patients with acute coronary syndrome in six Middle-Eastern countries.
Autorzy:: Ali WM; Department of Cardiology, Hamad Medical Corporation (HMC), Qatar and Weill Cornell Medical College, Doha, Qatar.
Zubaid M
El-Menyar A
Al Mahmeed W
Al-Lawati J
Singh R
Ridha M
Al-Hamdan R
Alhabib K
Al Suwaidi J; Pokaż więcej
Źródło:: Blood pressure [Blood Press] 2011 Feb; Vol. 20 (1), pp. 20-6. Date of Electronic Publication: 2010 Sep 15.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Acute Coronary Syndrome/*complications
Hypertension/*complications
Myocardial Infarction/*complications
Acute Coronary Syndrome/epidemiology ; Acute Coronary Syndrome/therapy ; Age Factors ; Cerebrovascular Disorders/complications ; Diabetes Complications/epidemiology ; Electrocardiography ; Female ; Hospital Mortality ; Humans ; Hyperlipidemias/complications ; Hypertension/epidemiology ; Hypertension/therapy ; Male ; Middle Aged ; Middle East ; Myocardial Infarction/epidemiology ; Myocardial Infarction/mortality ; Myocardial Infarction/therapy ; Peripheral Arterial Disease/complications ; Prevalence ; Prospective Studies ; Risk Factors ; Smoking/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Inflammatory myofibroblastic tumor of the right atrium.
Autorzy:: Jha NK; Division of Adult Cardiac Surgery, Sheikh Khalifa Medical City (Managed by Cleveland Clinic), P.O. Box 51900, Abu Dhabi, UAE.
Trudel M
Eising GP
Lange P
Al Sousi A
Al Mahmeed W
Khan JA
Saleh MA
Von Canal F
Misra VK
Augustin N; Pokaż więcej
Źródło:: Case reports in medicine [Case Rep Med] 2010; Vol. 2010. Date of Electronic Publication: 2010 Sep 19.
Typ publikacji:: Case Reports

Raport

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Heart failure in patients hospitalized with acute coronary syndromes: observations from the Gulf Registry of Acute Coronary Events (Gulf RACE).
Autorzy:: Alsheikh-Ali AA; Division of Cardiology, Institute of Cardiac Sciences, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. />Al-Mallah MH
Al-Mahmeed W
Albustani N
Al Suwaidi J
Sulaiman K
Zubaid M; Pokaż więcej
Corporate Authors:: Gulf RACE Investigators
Źródło:: European journal of heart failure [Eur J Heart Fail] 2009 Dec; Vol. 11 (12), pp. 1135-42. Date of Electronic Publication: 2009 Nov 04.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Acute Coronary Syndrome/*epidemiology
Heart Failure/*epidemiology
Acute Coronary Syndrome/complications ; Acute Coronary Syndrome/diagnosis ; Acute Coronary Syndrome/therapy ; Aged ; Female ; Heart Failure/complications ; Heart Failure/diagnosis ; Heart Failure/therapy ; Hospital Mortality ; Hospitalization ; Humans ; Male ; Middle Aged ; Middle East/epidemiology ; Prevalence ; Prognosis ; Registries ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Al Mahmeed, W."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język